Logo
    Search

    Podcast Summary

    • FDA Approves Over-the-Counter Sale of Narcan to Reverse Opioid OverdosesThe FDA's approval of over-the-counter sale of Narcan, a medication used to reverse opioid overdoses, is a significant development during the ongoing opioid crisis, making it easier for individuals to access this life-saving drug.

      The opioid crisis in America is a major issue, with Fentanyl being a significant contributor to overdoses, which are now at an all-time high. Over 100,000 people have died from drug overdoses in the past year, and the vast majority of those deaths were caused by opiates, including synthetic drugs like Fentanyl. However, there is a solution: Narcan, a medication used to reverse opioid overdoses, is soon to be available over the counter. This is a significant development, as people have been advocating for this for years during the ongoing opioid crisis. The FDA's approval of this medication will make it easier for individuals to access it and potentially save lives.

    • FDA's persistence led pharmaceutical companies to apply for OTC status for NarcanThe FDA's efforts, including providing mock-ups and threatening legal action, resulted in pharmaceutical companies applying for OTC status for Narcan, which builds upon previous state initiatives to make the drug more accessible

      The FDA pushed pharmaceutical companies to apply for over-the-counter (OTC) status for drugs like Narcan due to increasing pressure from states and advocacy groups. For years, these companies resisted, but the FDA's persistent actions, such as providing mock-ups of potential OTC packaging and threatening legal action, eventually led to applications. However, before this approval, various states had already implemented workarounds, like statewide standing orders, to make Narcan more accessible without an OTC version. These measures ranged from pharmacies providing the drug without a prescription to free vending machines with Narcan kits. Despite these efforts, accessibility varied greatly depending on the location. Overall, the FDA's recent approval is a significant development, but it builds upon years of work to make Narcan more accessible to the public.

    • Making Narcan over-the-counter: A shift towards harm reductionNew policy allows over-the-counter access to Narcan, a life-saving drug for opioid overdoses, symbolizing a move towards harm reduction and reducing overdose deaths.

      The recent move to make Narcan, an overdose reversal drug, available over the counter is a significant step towards reducing harm and saving lives for individuals using drugs, particularly those at risk due to the unpredictability and potency of illicit fentanyl. This change also symbolizes a shift in policy away from an abstinence-only approach to drug use and towards harm reduction. However, there are concerns that making Narcan more accessible could enable drug use for some. Public health officials are grappling with finding a balance between preventing overdose deaths and ensuring a pathway to treatment for those who use drugs. Ultimately, the goal is to keep people alive and give them the opportunity to seek help if they choose to do so.

    • The opioid crisis and its impact on young people during the pandemicThe opioid crisis, fueled by Fentanyl, is a complex issue impacting young people disproportionately during the pandemic. Access to life-saving drugs and prevention efforts are crucial.

      The stigma surrounding opioid use, particularly Fentanyl, is a significant issue contributing to the current crisis. Greater availability of drugs like Narcan could potentially encourage more use, but the reality is that many people are using these substances regardless. The conversation around drug use has shifted due to the emergence of a new drug market during the COVID-19 pandemic, where Fentanyl is increasingly present in various forms, including cocaine and fake pills. This has led to accidental overdoses among individuals who may not be regular drug users, making the issue feel more random and alarming to the public. The opioid crisis is particularly impactful on young people, with no end in sight, and unlike the COVID-19 pandemic, which is gradually improving, this crisis seems to be worsening. It's crucial to address the issue and provide access to life-saving drugs while also making them harder to obtain to encourage caution. However, the high number of overdose deaths each year indicates that this is a complex issue requiring a multi-faceted approach.

    • Mint Mobile's wireless offer vs Narcan's opioid reversal toolMint Mobile offers a 3-month unlimited plan for $15/month with a $45 upfront fee, while Narcan is a nasal spray that reverses opioid overdoses, restoring breathing and preventing brain damage.

      Mint Mobile is currently offering new customers a deal where they can get a 3-month unlimited wireless plan for $15 a month, but a $45 upfront payment is required. This offer is only available to new customers on their first 3-month plan and comes with slower speeds above 40 GB on the unlimited plan. Additionally, taxes, fees, and other restrictions apply. Meanwhile, in a completely different context, Narcan is a brand name for the drug naloxone, which works by replacing opioids on the opioid receptors in the brain and spinal cord, thus reversing the effects of an opioid overdose. This can help restore breathing and prevent brain damage. Narcan comes in a nasal spray form and can be administered up to 2 to 8 minutes before the person comes out of the overdose state, although they may experience withdrawal symptoms upon revival. So, whether you're looking to save on your wireless bill or help someone in an opioid emergency, these are important things to know. For more information on Mint Mobile's offer, visit mintmobile.com/explained. And for those interested in Narcan, it's a simple yet effective tool for reversing opioid overdoses.

    • Making Narcan Accessible: A Lifesaver in Opioid CrisisNarcan, a drug used to reverse opioid overdoses, is becoming more accessible, saving lives by enabling immediate intervention before emergency services arrive.

      Narcan, a life-saving drug used to reverse opioid overdoses, is becoming increasingly accessible and commonplace in various settings, including schools, churches, workplaces, and even personal possessions. Its ease of use and portability make it a valuable tool for individuals who may have loved ones or acquaintances struggling with opioid addiction. However, it's crucial to use it only in cases of overdose, as it has no effect on those not taking opioids. The urgency to distribute Narcan widely stems from the potency and speed of modern opioids, such as fentanyl, which can lead to fatal overdoses within minutes. Therefore, having Narcan readily available can potentially save lives by enabling immediate intervention before emergency services arrive.

    • FDA's Decision on OTC Naloxone: Potential Impact UncertainThe FDA's decision to allow OTC sales of naloxone, a drug to reverse opioid overdoses, could impact overdose numbers, but the extent is uncertain due to pricing and competition.

      The FDA's decision to allow an over-the-counter sale of a brand of naloxone, a drug used to reverse opioid overdoses, could potentially make a significant impact on overdose numbers. However, the extent of this impact is uncertain due to factors like pricing and competition from other drugmakers. The tranquilizer "tranq" and benzos are not affected by naloxone, and health professionals recommend administering it even if another substance might be the cause of an overdose. The first drugmaker to go over the counter is leading the way, but a nonprofit pharmaceutical company is also working on a nearly free version. The pricing and competition from other companies will determine how accessible and affordable naloxone becomes, which could ultimately influence its impact on overdose numbers.

    • Expanding real estate portfolios despite market downturnSome investors see opportunities to grow their real estate portfolios despite falling demand and prices, like Fundrise with its $1bn portfolio expansion plan. Always evaluate investment details before investing.

      Despite high interest rates causing a downturn in the real estate market, with dropping demand and falling prices, some investors are seeing opportunities to expand their portfolios. The Fundrise flagship fund, for instance, plans to grow its $1 billion real estate portfolio. This fund can be easily added to an investor's portfolio with a minimum investment of $10, by visiting fundrise.com/fox. However, it's crucial to thoroughly evaluate the investment objectives, risks, charges, and expenses before investing. This information can be found on the fund's website, at fundrise.com/flagship. This advertisement is paid.

    Recent Episodes from Today, Explained

    Panic! At The White House

    Panic! At The White House
    Joe Biden needed to win the debate. He didn’t. Vox’s Christian Paz explains if Democrats can find a better candidate. This episode was produced by Miles Bryan and Denise Guerra, edited by Matt Collette, fact-checked by Laura Bullard and Victoria Chamberlin, engineered by Patrick Boyd, Rob Byers, and Andrea Kristinsdotter, and hosted by Sean Rameswaram. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 28, 2024

    How Spotify picks its winners

    How Spotify picks its winners
    No, Sabrina Carpenter probably isn’t paying the streamer to play “Espresso” every time you’re listening to music. But the app is making changes to its business model that could impact your listening. This episode was produced by Peter Balonon-Rosen, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Rob Byers and Andrea Kristinsdotter, and hosted by Sean Rameswaram. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 27, 2024

    The end of Made in China?

    The end of Made in China?
    President Biden recently raised Trump-era tariffs, which could lead to even higher prices on Chinese imports. US Trade Representative Katherine Tai explains the Biden administration’s approach to trade with China, and Vox’s Dylan Matthews helps make sense of the changes. This episode was produced by Miles Bryan with help from Victoria Chamberlin, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Andrea Kristinsdottir and Patrick Boyd, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 26, 2024

    It’s not Islamophobic, it’s anti-Palestinian

    It’s not Islamophobic, it’s anti-Palestinian
    Islamophobic and antisemitic incidents are on the rise. Author Moustafa Bayoumi and Vox’s Abdallah Fayyad tell us about another kind of invisible discrimination: anti-Palestinian racism. This show was produced by Haleema Shah and Victoria Chamberlin, edited by Miranda Kennedy, fact checked by Victoria Chamberlin, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 25, 2024

    Why investors look past Elon’s musk

    Why investors look past Elon’s musk
    Elon Musk has had inappropriate relationships with SpaceX employees. Tesla shareholders knew that, and chose to reward him with a massive payday anyway. The Wall Street Journal’s Joe Palazzolo and The Verge’s Andrew Hawkins explain. This episode was produced by Amanda Lewellyn, edited by Amina Al-Sadi, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 24, 2024

    How UFC explains USA

    How UFC explains USA
    The Ultimate Fighting Championship went from niche bloodsport to multibillion-dollar league. Donald Trump might be its biggest fan. Journalists Luke Thomas and Sam Eagan explain the culture and politics of the UFC. This episode was produced by Hady Mawajdeh, edited by Lissa Soep, fact-checked by Laura Bullard, engineered by Andrea Kristinsdottir and Patrick Boyd, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 21, 2024

    It’s not easy being a green conservative

    It’s not easy being a green conservative
    Fighting climate change is not a very common Republican position. Climate activist Benji Backer argues it should be, and Climate Capitalism author Akshat Rathi explains how the free market could play a role. This episode was produced by Avishay Artsy, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Andrea Kristinsdottir and Rob Byers, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 20, 2024

    France's far-right youth

    France's far-right youth
    President Macron has called snap elections in France that could lead to him sharing power with the far right. Le Monde's Gilles Paris explains how the anti-immigrant party of Marine Le Pen is becoming more popular among young voters. This episode was produced by Denise Guerra with help from Victoria Chamberlin and Hady Mawajdeh, edited by Miranda Kennedy, fact-checked by Laura Bullard, engineered by Andrea Kristinsdottir and Patrick Boyd, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 18, 2024

    Save Darfur, again

    Save Darfur, again
    A bloody civil war is spreading famine and fear through Sudan. It’s a near-repeat of a crisis from two decades ago, but this time Sudan is not commanding the world’s attention the way the “Save Darfur” movement did. This episode was produced by Peter Balonon-Rosen, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 17, 2024

    Party in the USA?

    Party in the USA?
    How do you talk about colonialism and slavery at a birthday party? New York City is trying to tackle that question this year as it turns 400, and the US will soon have to do the same for its 250th. This episode was produced by Peter Balonon-Rosen and Haleema Shah, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Patrick Boyd, and hosted by Noam Hassenfeld. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Today, Explained
    enJune 14, 2024

    Related Episodes

    What if You Could Save Someone From an Overdose?

    What if You Could Save Someone From an Overdose?

    In the face of an escalating opioid epidemic, the F.D.A. recently approved over-the-counter sales for Narcan — a lifesaving nasal spray that can reverse an opioid overdose. 

    Jan Hoffman, who covers health law for The Times, explains why the new availability of Narcan could change the trajectory of the epidemic.

    Guest: Jan Hoffman, a health law correspondent for The New York Times.

    Background reading: 

    For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

    TAP62 Mike Todd

    TAP62 Mike Todd
    Mike Todd joins TAP today to discuss the latest advocacy efforts happening in South Carolina. Mike has worked hard to bring legitimacy to recovery housing and is an active voice for the Recovery Advocacy Project in SC. You can follow Mike at www.freedomrecoverycenterofgreenville.org and www.recoveryvoices.com. This episode also celebrates 200 overdose reversals for Challenges Inc, a South Carolina syringe services program. Learn more at www.challengesinc.org

    Pneumonia Associated COVID-19; Inaccurate Tests; Neck Gaiters; Drug Applications Halted; Narcan Update

    Pneumonia Associated COVID-19; Inaccurate Tests; Neck Gaiters; Drug Applications Halted; Narcan Update

    Treatment shows promise for patients who had pneumonia associated with COVID-19; A COVID-19 test that may have given inaccurate results; Neck gaiters as face masks may actually spread the virus; Drug applications are halted by the FDA; And Narcan has it’s shelf life extended. Also, we recap drug pipeline news from the past week.

    Vancouver’s Unconventional Approach to Its Fentanyl Crisis

    Vancouver’s Unconventional Approach to Its Fentanyl Crisis

     An influx of Fentanyl, a highly lethal synthetic narcotic, has aggravated the opioid crisis in the United States and prompted communities to scramble for ways to lower the skyrocketing rates of overdose deaths.

    In Vancouver, a Canadian city that has been at the forefront of innovative approaches to drug use, a novel and surprising tactic is being tried: It’s called “safer supply.”

    Guest: Stephanie Nolen, a global health reporter for The New York Times.

    Background reading: 

    For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.